Fri Feb 1, 2008 3:32am EST PARIS, Jan 31 (Reuters) – French authorities have opened a formal investigation into two managers from drugs groups GlaxoSmithKline (GSK.L: Quote, Profile, Research) and Sanofi Pasteur over a vaccination campaign in the 1990s, a judicial source said late on Thursday.
Judge Marie-Odile Bertella-Geffroy also opened an investigation for manslaughter against Sanofi Pasteur MSD, a joint venture between Sanofi Aventis (SASY.PA: Quote, Profile, Research) and Merck (MRK.N: Quote, Profile, Research), the same source said.
The investigations follow allegations that the companies failed to fully disclose side effects from an anti-hepatitis B drug used in a vaccination campaign between 1994 and 1998.
There was no immediate comment from the companies or the two managers involved.
From 1994 to 1998, almost two thirds of the French population and almost all newborn babies were vaccinated against hepatitis B, but the campaign was suspended after concerns arose about possible secondary effects from the treatments.
Some 30 plaintiffs have launched a civil action in the case, including the families of five people who died after vaccination.
(Reporting by Thierry Leveque; Writing by James Mackenzie; Editing by David Holmes)
Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]
www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the
copyright owner.
